Owing to the increased interest in brain ischemia and the new therapeutic options from pharmaceutical companies for the treatment of acute stroke, the author, one of the world's stroke experts, has revised the earlier edition of this book. It is the emergence of huge possibilities in the management of stroke--ultra-early diagnosis, intensive care, surgical and other interventional therapies, thrombolysis, anti-ischemic drugs and prevention of immediate recurrence--which necessitates this timely update.